Related Experiment Video
Updated: May 13, 2026

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
Published on: May 28, 2019
Perioperative cardioprotection
May Km Leung1, Michael G Irwin
1Department of Anaesthesiology, University of Hong Kong / Queen Mary Hospital Hong Kong SAR, China.
Insights
Perioperative cardiac complications are a major risk during non-cardiac surgery, especially with high cardiovascular disease prevalence. Aspirin and statins are strongly recommended to reduce this risk, while beta-blockers require careful titration for high-risk patients.
Area of Science:
- Anesthesiology and Perioperative Medicine
- Cardiology
- Pharmacology
Background:
- Non-cardiovascular surgery carries significant perioperative cardiac risks, contributing to morbidity and mortality.
- The rising prevalence of cardiovascular disease exacerbates these risks.
- Anesthesia is generally safe, but managing cardiac complications remains critical.
Purpose of the Study:
- To review pharmacological strategies for mitigating perioperative cardiac complications during non-cardiovascular surgery.
- To highlight evidence-based recommendations for medication use in at-risk surgical patients.
Main Methods:
- Review of current evidence and clinical guidelines.
- Analysis of pharmacological interventions for perioperative cardiac risk reduction.
Main Results:
- Aspirin and statins are strongly supported by current evidence for reducing perioperative cardiac risk.
- Beta-blockers may offer benefits in higher-risk populations but require careful titration and consideration of adverse effects.
Conclusions:
- Pharmacological interventions, particularly aspirin and statins, can significantly reduce perioperative cardiac complications.
- Careful patient selection and drug management, including beta-blockers, are essential for optimizing outcomes in high-risk surgical patients.
Abstract:
Although anaesthesia itself is now very safe, perioperative cardiac complications during non-cardiovascular surgery are a major cause of morbidity and mortality, because of the increasingly high underlying prevalence of cardiovascular disease. Fortunately, although there is no "magic bullet", pharmacological intervention can reduce the risk. In particular, current evidence strongly supports the use of aspirin and statins. Beta blockers may also be beneficial in higher risk groups but need to be titrated to effect, and their use requires careful consideration because of adverse effects in these patients.
Related Concept Videos
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Cardiopulmonary Resuscitation IV: Pharmacological Management
Cardiomyopathy V: Interprofessional Care
Cardiac Catheterization IV: Nursing Management
Peripheral Artery Disease V: Postoperative Nursing Management
Aneurysm IV: Nursing Management
